PAG
COGT icon

Private Advisor Group’s Cogent Biosciences COGT Stock Holding History

Private Advisor Group’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,125
Closed -$2K – 1905
2020
Q2 		$2K Buy
+1,125
New +$2.09K ﹤0.01% 3547

Other funds holding COGT

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Private Advisor Group's COGT Position: Q3 2020 in Review

Private Advisor Group sold out of Cogent Biosciences (COGT) in Q3 2020, closing a stake of 1,125 shares — an estimated $2K sold.

Private Advisor Group first reported a position in COGT in Q2 2020 and held it in 1 quarter. The position peaked at $2K in Q2 2020. 35 funds tracked by Wall St. Rank hold COGT as of Q3 2020.

  • Private Advisor Group reported no remaining Cogent Biosciences position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 1,125 Cogent Biosciences shares in Q3 2020, an estimated $2K.
  • Private Advisor Group first reported a position in Cogent Biosciences in Q2 2020 and held it in 1 quarter.
  • Private Advisor Group's Cogent Biosciences position peaked at $2K in Q2 2020.
  • 35 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.